Study Details

General Information

Kowa K-877-303

A Phase 3, Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study with a 40-Week, Active-Controlled, Open-Label Extension to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting Triglyceride Levels >500 mg/dL and <2000 mg/dL and Mild or Moderate Renal Impairment.

ProtocolK-877-303
Identifier
UID3d860235-9ba9-424e-9a7f-e309d5937037
StatusDone - Archived
Phase3
CategoryHigh Cholesterol / Adult
Launch Year2016
NCT Number-
Created2016-10-26 18:12
Last Updated2016-10-26 18:12

Description

No description provided.

Comment

PCRS

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment Open2017-01-03No
First Patient First VisitNo
Site Initiation Mtg.2016-12-16No
PI Meeting Start2016-12-01No
PI Meeting End2016-12-02No
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2018-07-25No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
RecruiterMiss, SalomonSMissNo
CoordinatorCervantes, EdgarECervantesNo
RegulatoryPerez, MyrnaMPerezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorKowa Research Institute, Inc.
DivisionKowa Research Institute
TeamKowa Research Institute
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROMedpace, Inc.
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?